These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 27699328)
1. Diagnosis and management of immune thrombocytopenia in childhood. Kühne T Hamostaseologie; 2017 Jan; 37(1):36-44. PubMed ID: 27699328 [TBL] [Abstract][Full Text] [Related]
2. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT; Gonzalez CE; Sandler SG Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic approach and treatment of immune thrombocytopenia in adults]. Kolonić SO; Patekar MB; Milunović V Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250 [TBL] [Abstract][Full Text] [Related]
4. Controversies in the treatment of immune thrombocytopenia. Cuker A; Cines DB; Neunert CE Curr Opin Hematol; 2016 Sep; 23(5):479-85. PubMed ID: 27380558 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and Therapy of Immune thrombocytopenia]. Matzdorff A; Wörmann B Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276 [TBL] [Abstract][Full Text] [Related]
6. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related]
7. ITP and international guidelines: what do we know, what do we need? Rodeghiero F; Ruggeri M Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296 [TBL] [Abstract][Full Text] [Related]
8. Current options for the treatment of idiopathic thrombocytopenic purpura. Arnold DM; Kelton JG Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468 [TBL] [Abstract][Full Text] [Related]
9. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
10. Contemporary management of primary immune thrombocytopenia in adults. Lakshmanan S; Cuker A J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415 [TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis and therapy of immune thrombocytopenia]. Giagounidis A Dtsch Med Wochenschr; 2024 Aug; 149(15):895-903. PubMed ID: 39013410 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune thrombocytopenia (ITP) during pregnancy in a woman that underwent a splenectomy during childhood. Paternoster DM; Bertolino M; Garofalo G; Merati E; Lunghi M; Surico N Minerva Ginecol; 2008 Dec; 60(6):555-6. PubMed ID: 18981983 [No Abstract] [Full Text] [Related]
13. Immune Thrombocytopenia in Children: Consensus and Controversies. Singh G; Bansal D; Wright NAM Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692 [TBL] [Abstract][Full Text] [Related]
14. Sequence of treatments for adults with primary immune thrombocytopenia. George JN Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032 [TBL] [Abstract][Full Text] [Related]
16. Successful implementation of a watchful waiting strategy for children with immune thrombocytopenia. Bekker E; Rosthøj S Dan Med Bull; 2011 Apr; 58(4):A4252. PubMed ID: 21466762 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. George JN Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309 [TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment. Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087 [TBL] [Abstract][Full Text] [Related]
19. [Current treatment of primary immune thrombocytopenia]. Lozano ML; Vicente V Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409 [TBL] [Abstract][Full Text] [Related]
20. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. Journeycake JM Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]